Wai Conrad
CEO, Counterpart Health
Wai Conrad has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Oct 19, 2026.
On the most recent filing, Wai Conrad is listed as CEO, Counterpart Health at CLOVER HEALTH INVESTMENTS, CORP. /DE. Inside the rolling window, Wai Conrad reported no open-market purchases and 4 open-market sales totaling $2.5M in CLOV. The largest disclosed transaction in the window is a sale of 300,000 CLOV shares on Sep 15, 2026, worth $1.4M.
Companies traded
Other insiders at CLOV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wai Conrad made?
Wai Conrad has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Wai Conrad trade?
Wai Conrad has filed SEC Form 4 disclosures for 1 company, including CLOV.
When was Wai Conrad's most recent SEC Form 4 filing?
Wai Conrad's most recent SEC Form 4 filing on Tracefour is dated Oct 19, 2026.
What is Wai Conrad's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Wai Conrad is listed as CEO, Counterpart Health.
What is Wai Conrad's total buy and sell value in the current window?
Inside the rolling retention window, Wai Conrad bought $0 and sold $2.5M based on SEC Form 4 filings.
What was Wai Conrad's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 300,000 CLOV shares on 2026-09-15, worth $1.4M, per SEC Form 4 filings.